Clinical implications of genetic advances in charcot-marie-tooth disease

Nature Reviews Neurology

Volumn 9, Issue 10, 2013, Pages 562-571

  Rossor, Alexander M ^a   Polke, James M ^b   Houlden, Henry ^a   Reilly, Mary M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CMT GENE; DISEASE ASSOCIATION; FAMILY HISTORY; GENE; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IDIOPATHIC AXONAL NEUROPATHY; MOLECULAR PATHOLOGY; NEUROPATHY; NEXT GENERATION SEQUENCING; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

CHARCOT-MARIE-TOOTH DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; SEQUENCE ANALYSIS, DNA;

EID: 84885668385     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2013.179     Document Type: Article

References (32)

1. Reilly, M. M., Murphy, S. M. & Laura, M. Charcot-Marie-Tooth disease. J. Peripher. Nerv. Syst. 16, 1-14 (2011).
2. Ouvrier, R. What can we learn from the history of Charcot-Marie-Tooth disease? Dev. Med. Child. Neurol. 52, 405-406 (2010).
3. Davis, C. J., Bradley, W. G. & Madrid, R. The peroneal muscular atrophy syndrome: Clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J. Genet. Hum. 26, 311-349 (1978).
4. Houlden, H. et al. Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type Neurology 71, 1660-1668 (2008).
5. Raeymaekers, P. et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul. Disord. 1, 93-97 (1991).
6. Murphy, S. M. et al. Charcot-Marie-Tooth disease: Frequency of genetic subtypes and guidelines for genetic testing. J. Neurol. Neurosurg. Psychiatry 83, 706-710 (2012).
7. Cottenie, E. et al. Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy. Neuromuscul. Disord. 23, 399-403 (2013).
8. Houlden, H. et al. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul. Disord. 19, 264-269 (2009).
9. Michell, A. W. et al. GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatment. J. Neurol. Neurosurg. Psychiatry 80, 699-700 (2009).
10. Houlden, H. et al. Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). Brain 129, 411-425 (2006).
11. Saporta, A. S. et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann. Neurol. 69, 22-33 (2011).
12. Schouten, J. P. et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002).
13. Rehm, H. L. Disease-targeted sequencing: A cornerstone in the clinic. Nat. Rev. Genet. 14, 295-300 (2013).
14. Lupski, J. R. et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 362, 1181-1191 (2010).
15. Landoure, G. et al. Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family. Neurology 79, 192-194 (2012).
16. NHLBI Exome Sequencing Project (ESP). Exome Variant Server [online], http://evs.gs.washington.edu/EVS.
17. Pitceathly, R. D. et al. Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology 79, 1145-1154 (2012).
18. Chaudhry, R. et al. Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation. Muscle Nerve 47, 922-924 (2013).
19. Liao, J. P. & Waclawik, A. J. Nerve root hypertrophy in CMT type 1A. Neurology 62, 783 (2004).
20. Ishigami, N., Kondo, M. & Nakagawa, M. Case of Charcot-Marie-Tooth disease type 1A with increased cerebrospinal fluid proteins and nerve root hypertrophy [Japanese]. Rinsho Shinkeigaku 48, 419-421 (2008).
21. d?Ydewalle, C. et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med. 17, 968-974 (2011).
22. Patzko, A. et al. Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain 135, 3551-3566 (2012).
23. Sereda, M. W., Meyer zu Horste, G., Suter, U., Uzma, N. & Nave, K. A. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat. Med. 9, 1533-1537 (2003).
24. Garofalo, K. et al. Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J. Clin. Invest. 121, 4735-4745 (2011).
25. Passage, E. et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10, 396-401 (2004).
26. Burns, J. et al. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: A randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 8, 537-544 (2009).
27. Micallef, J. et al. Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 8, 1103-1110 (2009).
28. Pareyson, D. et al. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): A double-blind randomised trial. Lancet Neurol. 10, 320-328 (2011).
29. Singer, M. A., Vernino, S. A. & Wolfe, G. I. Idiopathic neuropathy: New paradigms, new promise. J. Peripher. Nerv. Syst. 17 (SUPPL. 2), 43-49 (2012).
30. Klein, C. J. et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat. Genet. 43, 595-600 (2011).
31. MacLeod, R. et al. Recommendations for the predictive genetic test in Huntington?s disease. Clin. Genet. 83, 221-231 (2013).
32. Davidson, G. et al. Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J. Neurol. 259, 1673-1685 (2012).